SlideShare a Scribd company logo
Regina LaBelle, Chief of Staff
Office of National Drug Control Policy
April 23, 2014
Vision Session
National RX Drug Abuse Summit
0
5
10
15
20
25
1980
1982
1984
1986
1988
1990
1992
1994
1996
1998
2000
2002
2004
2006
2008
2010
Deathsper100,000population
Motor Vehicle Traffic Poisoning Drug Poisoning (Overdose)
Source: NCHS Data Brief, December, 2011, Updated with 2009 and 2010 mortality data
U.S. Death Rate Trends, 1980-2010
Source of Prescription Pain Relievers
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2010
•  Coordinated effort across
the Federal Government
•  Four focus areas:
1)  Education
2)  Prescription Drug
Monitoring Programs
3)  Proper Disposal of
Medication
4)  Enforcement
Prescription Drug Abuse
Prevention Plan
Source: PDMP Training and Technical Assistance Center, Brandeis University, 2013
Prescription Drug Monitoring Programs
How to Recognize and Respond
to an Opioid Overdose
•  The American Society of Anesthesiologists (ASA) has
created a card explaining how to recognize and respond
to an opioid overdose.
•  The card, called “Opioid Overdose Resuscitation,” is
available for download on the ASA Web site.
•  To download the card, go to: http://www.asahq.org/
WhenSecondsCount/resources
•  There are signs that efforts to reduce and prevent prescription drug
abuse are working.
o  National data show the rate of past-month nonmedical use of prescription
medicines among young adults aged 18 to 25 over the past two years is lower
than the rate from 2003 - 2010.1
•  State public health and public safety professionals can take steps to
promote safer prescribing practices; improved prescription monitoring;
safe disposal; and effective monitoring, intervention, treatment and
overdose prevention.
•  Long-term success will come from coordination and collaboration at the
Federal, state, local, and tribal levels, particularly among public health and
public safety leaders.
Conclusion
1 Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National
Findings. U.S. Department of Health and Human Services. [September 2013]. Available: http://www.samhsa.gov/data/NSDUH/
2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm
For More Information:
WHITEHOUSE.GOV/ONDCP

More Related Content

What's hot

TRAINING 2 Unpacking Tennessee Adolescent Substance Misuse Data
TRAINING 2  Unpacking Tennessee Adolescent Substance Misuse DataTRAINING 2  Unpacking Tennessee Adolescent Substance Misuse Data
TRAINING 2 Unpacking Tennessee Adolescent Substance Misuse Data
KarenChenoaSergent
 
Statewide Narcotics Screening Project
Statewide Narcotics Screening ProjectStatewide Narcotics Screening Project
Statewide Narcotics Screening Project
Trevor Rohm
 
Webinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% SolutionWebinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% Solution
Canadian Organization for Rare Disorders
 
Pres arm2011 jun11_long
Pres arm2011 jun11_longPres arm2011 jun11_long
Pres arm2011 jun11_longsoder145
 
Partnering with Communities in Survey Design, Implementation and Dissemination
Partnering with Communities in Survey Design, Implementation and DisseminationPartnering with Communities in Survey Design, Implementation and Dissemination
Partnering with Communities in Survey Design, Implementation and Dissemination
soder145
 
The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.
Paul Coelho, MD
 
Green pt1 state-pmp
Green pt1 state-pmpGreen pt1 state-pmp
Green pt1 state-pmpWelcome40
 
Minnesota’s accountable communities for health
Minnesota’s accountable communities for health Minnesota’s accountable communities for health
Minnesota’s accountable communities for health
soder145
 
Sample Frame Assessment for a Large Metropolitan County's Health Survey
Sample Frame Assessment for a Large Metropolitan County's Health SurveySample Frame Assessment for a Large Metropolitan County's Health Survey
Sample Frame Assessment for a Large Metropolitan County's Health Survey
soder145
 
Overview of the MNHA survey, methodology, and evidence of the impact of the a...
Overview of the MNHA survey, methodology, and evidence of the impact of the a...Overview of the MNHA survey, methodology, and evidence of the impact of the a...
Overview of the MNHA survey, methodology, and evidence of the impact of the a...
soder145
 
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDAPolitico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
CVS Health
 
Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...
Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...
Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...
soder145
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
OPUNITE
 
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Canadian Organization for Rare Disorders
 
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Canadian Organization for Rare Disorders
 
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Canadian Organization for Rare Disorders
 
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionSummer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Canadian Organization for Rare Disorders
 
Addressing Rising Health Care Costs | CVS Health
Addressing Rising Health Care Costs | CVS HealthAddressing Rising Health Care Costs | CVS Health
Addressing Rising Health Care Costs | CVS Health
CVS Health
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015
yahyasultan
 
Changing Trends in Employer Sponsored Insurance After the Affordable Care Act
Changing Trends in Employer Sponsored Insurance After the Affordable Care ActChanging Trends in Employer Sponsored Insurance After the Affordable Care Act
Changing Trends in Employer Sponsored Insurance After the Affordable Care Act
soder145
 

What's hot (20)

TRAINING 2 Unpacking Tennessee Adolescent Substance Misuse Data
TRAINING 2  Unpacking Tennessee Adolescent Substance Misuse DataTRAINING 2  Unpacking Tennessee Adolescent Substance Misuse Data
TRAINING 2 Unpacking Tennessee Adolescent Substance Misuse Data
 
Statewide Narcotics Screening Project
Statewide Narcotics Screening ProjectStatewide Narcotics Screening Project
Statewide Narcotics Screening Project
 
Webinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% SolutionWebinar 3: Bringing Home the 5% Solution
Webinar 3: Bringing Home the 5% Solution
 
Pres arm2011 jun11_long
Pres arm2011 jun11_longPres arm2011 jun11_long
Pres arm2011 jun11_long
 
Partnering with Communities in Survey Design, Implementation and Dissemination
Partnering with Communities in Survey Design, Implementation and DisseminationPartnering with Communities in Survey Design, Implementation and Dissemination
Partnering with Communities in Survey Design, Implementation and Dissemination
 
The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.The economic burden of prescription opioid overdose... 2013.
The economic burden of prescription opioid overdose... 2013.
 
Green pt1 state-pmp
Green pt1 state-pmpGreen pt1 state-pmp
Green pt1 state-pmp
 
Minnesota’s accountable communities for health
Minnesota’s accountable communities for health Minnesota’s accountable communities for health
Minnesota’s accountable communities for health
 
Sample Frame Assessment for a Large Metropolitan County's Health Survey
Sample Frame Assessment for a Large Metropolitan County's Health SurveySample Frame Assessment for a Large Metropolitan County's Health Survey
Sample Frame Assessment for a Large Metropolitan County's Health Survey
 
Overview of the MNHA survey, methodology, and evidence of the impact of the a...
Overview of the MNHA survey, methodology, and evidence of the impact of the a...Overview of the MNHA survey, methodology, and evidence of the impact of the a...
Overview of the MNHA survey, methodology, and evidence of the impact of the a...
 
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDAPolitico Pro Health Care Briefing: Drug Safety and the Trump FDA
Politico Pro Health Care Briefing: Drug Safety and the Trump FDA
 
Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...
Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...
Location, Location, Location: Leveraging Interactive Maps and ZIP Code Level ...
 
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_externalWed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
 
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
Roadmap to Optimal Drug Access (Chris Bonnett, H3 Consulting) June 14, 2017
 
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
Roadmap to Optimal Drug Access (Vivian Leong MOHLTC) June 14, 2017
 
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
Roadmap to Optimal Drug Access (Neil Palmer, PDCI) June 14, 2017
 
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal ElectionSummer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
Summer Webinar 1: Aligning on Rare Drug Strategy, PMPRB, and Federal Election
 
Addressing Rising Health Care Costs | CVS Health
Addressing Rising Health Care Costs | CVS HealthAddressing Rising Health Care Costs | CVS Health
Addressing Rising Health Care Costs | CVS Health
 
Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015Challenges of pharmaceutical industry in 2015
Challenges of pharmaceutical industry in 2015
 
Changing Trends in Employer Sponsored Insurance After the Affordable Care Act
Changing Trends in Employer Sponsored Insurance After the Affordable Care ActChanging Trends in Employer Sponsored Insurance After the Affordable Care Act
Changing Trends in Employer Sponsored Insurance After the Affordable Care Act
 

Similar to Wed vs ondcp labelle

Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
OPUNITE
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0
satoriwatersfl
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
OPUNITE
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
OPUNITE
 
Intro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest LectureIntro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest Lecture
Julie Hynes
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
ShirazKhokhar1
 
150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL
150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL
150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINALLeah Ramirez
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
OPUNITE
 
Drug abuse a public health concern
Drug abuse a  public health concernDrug abuse a  public health concern
Drug abuse a public health concern
Ishtiaque Khan
 
State profile -_florida
State profile -_floridaState profile -_florida
State profile -_florida
satoriwatersfl
 
Drugs & alcohol scoping workshop 3-6-15 final
Drugs & alcohol scoping workshop  3-6-15 finalDrugs & alcohol scoping workshop  3-6-15 final
Drugs & alcohol scoping workshop 3-6-15 final
CambridgeshireInsight
 
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™
 
Ea 4 cline raduka_wood
Ea 4 cline raduka_woodEa 4 cline raduka_wood
Ea 4 cline raduka_wood
OPUNITE
 
Tue vs ondcp spitznas
Tue vs   ondcp spitznasTue vs   ondcp spitznas
Tue vs ondcp spitznas
OPUNITE
 
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwardsRx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
OPUNITE
 
PRC Region 8 Regional Needs Assessment Overview
PRC Region 8 Regional Needs Assessment OverviewPRC Region 8 Regional Needs Assessment Overview
PRC Region 8 Regional Needs Assessment Overview
Prevention Resource Center Region 8
 
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberryRx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
OPUNITE
 
IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...
IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...
IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...Ardhany Rc
 
Maldives National drug use survey 2012
Maldives National drug use survey 2012Maldives National drug use survey 2012
Maldives National drug use survey 2012
Achmed Adam
 

Similar to Wed vs ondcp labelle (20)

Tuesday astho
Tuesday asthoTuesday astho
Tuesday astho
 
State profile -_new_york_0
State profile -_new_york_0State profile -_new_york_0
State profile -_new_york_0
 
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazonRx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
Rx15 tt tues_1230_1_carnevale_2green_3paone-tuazon
 
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welchRx16 federal tues_330_1_spitznas_2baldwin_3welch
Rx16 federal tues_330_1_spitznas_2baldwin_3welch
 
Intro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest LectureIntro to Prevention: Psychopharmacology Guest Lecture
Intro to Prevention: Psychopharmacology Guest Lecture
 
20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt20130909-best practices work group-presentation.ppt
20130909-best practices work group-presentation.ppt
 
150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL
150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL
150929 Prevention of Opioid Pain Reliever Misuse in Arkansas FINAL
 
CR_drug_abuse_2016
CR_drug_abuse_2016CR_drug_abuse_2016
CR_drug_abuse_2016
 
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingWeb rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershing
 
Drug abuse a public health concern
Drug abuse a  public health concernDrug abuse a  public health concern
Drug abuse a public health concern
 
State profile -_florida
State profile -_floridaState profile -_florida
State profile -_florida
 
Drugs & alcohol scoping workshop 3-6-15 final
Drugs & alcohol scoping workshop  3-6-15 finalDrugs & alcohol scoping workshop  3-6-15 final
Drugs & alcohol scoping workshop 3-6-15 final
 
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse CrisisGlobal Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
Global Medical Cures™ | Responding to America's Prescription Drug Abuse Crisis
 
Ea 4 cline raduka_wood
Ea 4 cline raduka_woodEa 4 cline raduka_wood
Ea 4 cline raduka_wood
 
Tue vs ondcp spitznas
Tue vs   ondcp spitznasTue vs   ondcp spitznas
Tue vs ondcp spitznas
 
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwardsRx15 ea tues_330_1_lovedale_2holton_3varney-edwards
Rx15 ea tues_330_1_lovedale_2holton_3varney-edwards
 
PRC Region 8 Regional Needs Assessment Overview
PRC Region 8 Regional Needs Assessment OverviewPRC Region 8 Regional Needs Assessment Overview
PRC Region 8 Regional Needs Assessment Overview
 
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberryRx15 pdmp tues_330_1_brown_2fondario_3quesinberry
Rx15 pdmp tues_330_1_brown_2fondario_3quesinberry
 
IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...
IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...
IMPACT OF REHABILITATION RIGHT’S NEGLIGENCE FOR PEOPLE WHO USE DRUGS DURING T...
 
Maldives National drug use survey 2012
Maldives National drug use survey 2012Maldives National drug use survey 2012
Maldives National drug use survey 2012
 

More from OPUNITE

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
OPUNITE
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
OPUNITE
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
OPUNITE
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
OPUNITE
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
OPUNITE
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
OPUNITE
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
OPUNITE
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
OPUNITE
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
OPUNITE
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
OPUNITE
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
OPUNITE
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
OPUNITE
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
OPUNITE
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
OPUNITE
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
OPUNITE
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
OPUNITE
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
OPUNITE
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
OPUNITE
 

More from OPUNITE (20)

Dr. Tom Frieden keynote
Dr. Tom Frieden keynoteDr. Tom Frieden keynote
Dr. Tom Frieden keynote
 
Dr. Francis Collins keynote
Dr. Francis Collins keynoteDr. Francis Collins keynote
Dr. Francis Collins keynote
 
Kana Enomoto keynote
Kana Enomoto keynoteKana Enomoto keynote
Kana Enomoto keynote
 
Rx16 claad tue-vision_final
Rx16 claad tue-vision_finalRx16 claad tue-vision_final
Rx16 claad tue-vision_final
 
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinnerRx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
Rx16 tpp wed_330_1_stack_2nelson_3roberts_4skinner
 
Rx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copyRx16 general session_wed_800_1_volkow copy
Rx16 general session_wed_800_1_volkow copy
 
Rx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelliRx16 general session_900_1_botticelli
Rx16 general session_900_1_botticelli
 
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyWeb rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copy
 
Rx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsenRx16 treat wed_330_1_barnes_2clarkolsen
Rx16 treat wed_330_1_barnes_2clarkolsen
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategiesRx16 prev wed_330_workplace issues and strategies
Rx16 prev wed_330_workplace issues and strategies
 
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessWeb only rx16 pharma-wed_330_1_shelley_2atwood-harless
Web only rx16 pharma-wed_330_1_shelley_2atwood-harless
 
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichtingRx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
Rx16 pdmp wed_330_1_hoppe_2sun_3baumgartner-leichting
 
Rx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2priceRx16 len wed_330_1_ferdinand_2price
Rx16 len wed_330_1_ferdinand_2price
 
Rx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earleRx16 heroin wed_330_1_rader_2lynch-earle
Rx16 heroin wed_330_1_rader_2lynch-earle
 
Rx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblattRx16 clinical wed_330_1_saunders_2wexelblatt
Rx16 clinical wed_330_1_saunders_2wexelblatt
 
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanWeb only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4dean
 
Rx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_millerRx16 treat wed_200_group_falkinburg_miller
Rx16 treat wed_200_group_falkinburg_miller
 
Rx16 tpp wed_200_group
Rx16 tpp wed_200_groupRx16 tpp wed_200_group
Rx16 tpp wed_200_group
 
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnoldRx16 prevent wed_200_1_cairnes-wertnepy_2arnold
Rx16 prevent wed_200_1_cairnes-wertnepy_2arnold
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 

Wed vs ondcp labelle

  • 1. Regina LaBelle, Chief of Staff Office of National Drug Control Policy April 23, 2014 Vision Session National RX Drug Abuse Summit
  • 2. 0 5 10 15 20 25 1980 1982 1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 Deathsper100,000population Motor Vehicle Traffic Poisoning Drug Poisoning (Overdose) Source: NCHS Data Brief, December, 2011, Updated with 2009 and 2010 mortality data U.S. Death Rate Trends, 1980-2010
  • 3. Source of Prescription Pain Relievers Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2009-2010
  • 4. •  Coordinated effort across the Federal Government •  Four focus areas: 1)  Education 2)  Prescription Drug Monitoring Programs 3)  Proper Disposal of Medication 4)  Enforcement Prescription Drug Abuse Prevention Plan
  • 5. Source: PDMP Training and Technical Assistance Center, Brandeis University, 2013 Prescription Drug Monitoring Programs
  • 6. How to Recognize and Respond to an Opioid Overdose •  The American Society of Anesthesiologists (ASA) has created a card explaining how to recognize and respond to an opioid overdose. •  The card, called “Opioid Overdose Resuscitation,” is available for download on the ASA Web site. •  To download the card, go to: http://www.asahq.org/ WhenSecondsCount/resources
  • 7. •  There are signs that efforts to reduce and prevent prescription drug abuse are working. o  National data show the rate of past-month nonmedical use of prescription medicines among young adults aged 18 to 25 over the past two years is lower than the rate from 2003 - 2010.1 •  State public health and public safety professionals can take steps to promote safer prescribing practices; improved prescription monitoring; safe disposal; and effective monitoring, intervention, treatment and overdose prevention. •  Long-term success will come from coordination and collaboration at the Federal, state, local, and tribal levels, particularly among public health and public safety leaders. Conclusion 1 Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. U.S. Department of Health and Human Services. [September 2013]. Available: http://www.samhsa.gov/data/NSDUH/ 2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm